Top Page
GenusPlus Group Ltd.
(Sydney:GNP)
GenusPlus Group Ltd. (GNP) vs. iShares MSCI Australia ETF (EWA)
GenusPlus Group Ltd. Business Overview & Revenue Model
GenusPlus Group Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 751.27M | 751.27M | 551.19M | 444.18M | 451.15M | 318.21M |
| Gross Profit | 578.05M | 578.05M | 400.06M | 43.54M | 311.85M | 221.55M |
| EBITDA | 56.98M | 56.98M | 43.11M | 34.07M | 32.54M | 27.28M |
| Net Income | 35.37M | 35.37M | 19.26M | 13.41M | 13.56M | 13.35M |
Balance Sheet | ||||||
| Total Assets | 470.97M | 470.97M | 288.15M | 227.42M | 231.98M | 155.56M |
| Cash, Cash Equivalents and Short-Term Investments | 94.32M | 94.32M | 100.97M | 46.74M | 27.88M | 34.18M |
| Total Debt | 51.74M | 51.74M | 29.25M | 27.73M | 27.17M | 19.88M |
| Total Liabilities | 311.19M | 311.19M | 166.98M | 122.44M | 138.56M | 97.85M |
| Stockholders Equity | 159.78M | 159.78M | 121.17M | 104.98M | 93.42M | 57.71M |
Cash Flow | ||||||
| Free Cash Flow | 107.82M | 107.82M | 68.90M | 32.09M | 6.60M | -4.30M |
| Operating Cash Flow | 120.93M | 120.93M | 82.84M | 37.79M | 11.47M | 6.99M |
| Investing Cash Flow | -46.36M | -46.36M | -15.82M | -7.31M | -24.25M | -12.42M |
| Financing Cash Flow | -16.21M | -14.72M | -12.79M | -11.48M | 6.33M | -189.08K |
GenusPlus Group Ltd. Technical Analysis
GenusPlus Group Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | €625.04M | 19.60 | 16.18% | 3.28% | 45.23% | 43.94% | |
73 Outperform | AU$1.26B | 35.16 | 25.18% | 0.52% | 36.30% | 82.20% | |
72 Outperform | AU$733.86M | 17.20 | 8.35% | 4.32% | -21.57% | -34.09% | |
68 Neutral | AU$661.08M | 19.21 | 50.61% | 5.68% | 12.96% | 8.19% | |
67 Neutral | AU$1.14B | 30.25 | 7.98% | 1.80% | 1.81% | -23.89% | |
66 Neutral | AU$1.70B | 33.71 | 13.62% | 2.01% | 23.76% | 21.18% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
GenusPlus Group Ltd. Corporate Events
GenusPlus Group Ltd has released its corporate governance statement for the financial year ending 30 June 2025, which is available on their website. The statement confirms compliance with the ASX Corporate Governance Council’s principles and recommendations, detailing the company’s adherence to governance practices and outlining any deviations. This disclosure is significant for stakeholders as it provides transparency into the company’s governance framework and practices, potentially impacting investor confidence and the company’s market positioning.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has announced a proposed issue of 357,277 fully paid ordinary securities, with the issue date set for November 26, 2025. This move is part of the company’s strategy to enhance its capital structure, potentially impacting its market positioning and offering new opportunities for stakeholders.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has announced its Annual General Meeting (AGM) scheduled for 20 November 2025, to be held in Perth, Western Australia. Shareholders can participate by attending in person or voting by proxy, with the company encouraging active participation. This meeting is significant for stakeholders as it provides an opportunity to engage with the company’s board and discuss resolutions, reflecting GenusPlus Group’s commitment to transparency and shareholder involvement.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has been awarded three significant contracts by Fortescue Metals Group as part of Fortescue’s decarbonisation initiatives in Western Australia. The contracts, valued at approximately $60 million, involve the construction of transmission lines and power distribution infrastructure at Fortescue’s mining sites, with completion expected by the fourth quarter of 2026. This collaboration underscores GenusPlus’s ongoing commitment to supporting Fortescue’s efforts to achieve Real Zero terrestrial emissions by 2030, enhancing its position as a key player in the power and communications infrastructure industry.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has been awarded additional work under its contract with Western Power for the Clean Energy Link – North project, valued at approximately $50 million. This project aims to enhance the transmission network capacity in Western Australia to support renewable energy integration. Additionally, GenusPlus secured a $25 million contract for the Network Renewal Underground Power Pilot project, further strengthening its partnership with Western Power and reinforcing its position in the power infrastructure industry.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has announced its Annual General Meeting (AGM) will take place on 20 November 2025 in Perth, where the re-election of directors will be a key agenda item. The closing date for director nominations is set for 13 October 2025, marking a crucial timeline for stakeholders interested in the company’s governance. This meeting is significant as it will influence the company’s leadership and potentially its strategic direction.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has announced the application for quotation of 610,483 ordinary fully paid securities on the Australian Securities Exchange (ASX). These securities are issued under an employee incentive scheme and are not subject to transfer restrictions. This move is expected to enhance the company’s market presence and provide liquidity options for its stakeholders.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd. has announced a change in the director’s interest notice involving David William Riches. The change involved the disposal of 1,350,000 fully paid ordinary shares through an on-market trade, valued at $7,425,000. This adjustment in shareholding reflects a strategic move by the director, which may influence stakeholder perceptions and the company’s market positioning.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has announced a change in the indirect interest of its director, David William Riches, involving the disposal of 300,000 fully paid ordinary shares through an on-market trade. This transaction reflects a minor adjustment in the director’s holdings, with the total number of securities held indirectly reduced. The change is part of regular trading activities and does not indicate any significant shift in the company’s strategic direction or operations.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has announced a dividend distribution of AUD 0.036 per share for its ordinary fully paid securities. The dividend relates to the financial period ending on June 30, 2025, with an ex-date of September 30, 2025, and a payment date set for October 31, 2025. This announcement reflects the company’s ongoing commitment to providing returns to its shareholders.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$5.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd. has released its financial results for the fiscal year ending June 30, 2025. The company has highlighted its financial performance, workforce safety achievements, and outlook for FY2026. The announcement provides insights into the company’s operational segments and cash flow, indicating a focus on maintaining service contracts and improving safety performance. These results are expected to impact the company’s market positioning and stakeholder interests positively.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$5.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd reported a significant financial performance in FY2025, with revenue increasing by 36% to $751 million and normalised EBITDA rising by 49% to $67.4 million. The company achieved record-breaking results across revenue, EBITDA, and NPAT, driven by substantial growth in their order book and strategic acquisitions. The group’s expansion into the renewable energy sector and the acquisition of companies like CommTel Network Solutions and Partum Engineering have bolstered their market position. With a strong order book and tender pipeline, GenusPlus is well-positioned for continued growth, particularly as Australia transitions to renewable energy sources.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$5.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd. has reported a significant financial performance for the year ended 30 June 2025, with a 36.30% increase in revenue from ordinary activities, reaching $751,265,713. The company’s net profit before tax surged by 89.66% to $52,564,332, and profit after tax from ordinary activities rose by 83.62% to $35,369,224. The company declared a final fully franked dividend of 3.6 cents per share, totaling approximately $6,500,000, to be paid on 31 October 2025. GenusPlus Group Ltd. also expanded its operations by acquiring several entities, including Commtel Network Solutions Pty Ltd and Partum Engineering Pty Ltd, among others, and holds interests in joint ventures such as the Acciona Genus Joint Venture and the Samsung Genus Joint Venture.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$5.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd is set to release its FY2025 Financial Results and Investor Update on August 27, 2025, with a subsequent investor conference call hosted by Managing Director David Riches on August 28, 2025. This announcement is significant as it provides stakeholders with insights into the company’s financial performance and strategic direction, potentially impacting its operations and industry positioning.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$5.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd has announced the issuance of 178,541 fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX). This move is part of an employee incentive scheme, reflecting the company’s strategy to enhance employee engagement and align their interests with shareholder value, potentially impacting its market positioning positively.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$2.70 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.